SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-17-000250
Filing Date
2017-02-14
Accepted
2017-02-14 17:04:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 e615774_sc13ga-tapimmune.htm SC 13G/A 110907
2 e615774_ex-1.htm EX-1 5939
  Complete submission text file 0001193805-17-000250.txt   118529
Mailing Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102
Business Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102 (206) 504-7278
TAPIMMUNE INC (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-58217 | Film No.: 17610188
SIC: 2834 Pharmaceutical Preparations

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

IRS No.: 010786483 | State of Incorp.: DE
Type: SC 13G/A